Leukemia

Showing NaN - NaN of 75

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia Trial in Australia, Canada, United States (topotecan HCl)

Completed
  • Leukemia
  • topotecan hydrochloride
  • Long Beach, California
  • +37 more
Jul 23, 2014

Leukemia Trial in Worldwide (imatinib mesylate)

Completed
  • Leukemia
  • imatinib mesylate
  • Birmingham, Alabama
  • +234 more
Feb 20, 2014

Leukemia Trial in Australia, Canada, United States (drug, procedure, radiation)

Completed
  • Leukemia
  • Phoenix, Arizona
  • +50 more
Feb 18, 2014

Leukemia, MDS Trial in Australia, Canada, United States (asparaginase, cytarabine, gemtuzumab ozogamicin)

Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • Birmingham, Alabama
  • +75 more
Feb 18, 2014

Leukemia Trial in Worldwide (gemcitabine HCl)

Completed
  • Leukemia
  • gemcitabine hydrochloride
  • Birmingham, Alabama
  • +224 more
Feb 18, 2014

Leukemia Trial in Worldwide (asparaginase, busulfan, cyclophosphamide)

Completed
  • Leukemia
  • Birmingham, Alabama
  • +147 more
Feb 19, 2014

Leukemia Trial in Worldwide (filgrastim, asparaginase, cyclophosphamide)

Completed
  • Leukemia
  • filgrastim
  • +11 more
  • Birmingham, Alabama
  • +139 more
Feb 12, 2014

Neurobehavioral Complications in Children Who Were Previously

Completed
  • Leukemia
  • +3 more
  • management of therapy complications
  • psychosocial assessment and care
  • Phoenix, Arizona
  • +30 more
Jan 29, 2014

Leukemia Trial in Australia, Canada, United States (asparaginase, cyclophosphamide, cytarabine)

Completed
  • Leukemia
  • Long Beach, California
  • +34 more
Aug 23, 2013

Quality of Life in Children Treated for Cancer

Completed
  • Leukemia
  • +2 more
  • Quality of Life Forms
  • Duarte, California
  • +16 more
Aug 22, 2013

Leukemia Trial in Puerto Rico, South Africa, United States (theophylline)

Completed
  • Leukemia
  • Scottsdale, Arizona
  • +70 more
Aug 22, 2013

Leukemia Trial in Australia, Canada, United States (cytarabine, dexamethasone, etoposide)

Completed
  • Leukemia
  • Long Beach, California
  • +32 more
Aug 21, 2013

Leukemia Trial in Puerto Rico, South Africa, United States (sargramostim, cyclophosphamide, cytarabine)

Completed
  • Leukemia
  • sargramostim
  • +5 more
  • Scottsdale, Arizona
  • +64 more
Aug 16, 2013

Leukemia Trial in Puerto Rico, South Africa, United States (arsenic trioxide)

Completed
  • Leukemia
  • arsenic trioxide
  • Scottsdale, Arizona
  • +70 more
Jun 20, 2013

Leukemia, Lymphoma Trial in Ann Arbor, New York, Philadelphia (asparaginase, cyclophosphamide, cytarabine)

Completed
  • Leukemia
  • Lymphoma
  • Ann Arbor, Michigan
  • +3 more
Jun 19, 2013

Leukemia, Lymphoma Trial in United States (nelarabine)

Completed
  • Leukemia
  • Lymphoma
  • Mobile, Alabama
  • +90 more
Feb 4, 2013

Leukemia Trial in Australia, Canada, United States (etoposide, mitoxantrone HCl, valspodar)

Completed
  • Leukemia
  • Little Rock, Arkansas
  • +54 more
Jan 31, 2013

Collecting Tissue Samples From Leukemia or Other Blood Disorders

Unknown status
  • Leukemia
  • Lymphoma
  • biologic sample preservation procedure
  • Birmingham, Alabama
  • +213 more
Dec 5, 2012

Leukemia Trial in United States (biological, drug, procedure, radiation)

Completed
  • Leukemia
  • sargramostim
  • +17 more
  • Aurora, Colorado
  • +93 more
Nov 21, 2012

Leukemia Trial in United States (chemo, gemtuzumab ozogamicin)

Completed
  • Leukemia
  • Tucson, Arizona
  • +12 more
Aug 21, 2012

Leukemia Trial in Australia, Canada, United States (tipifarnib)

Completed
  • Leukemia
  • Little Rock, Arkansas
  • +60 more
Mar 14, 2012

Leukemia Trial in Worldwide (cyclophosphamide, fludarabine phosphate)

Completed
  • Leukemia
  • Anniston, Alabama
  • +217 more
Jan 26, 2010

Leukemia Trial in United States (Dasatinib, Imatinib)

Terminated
  • Leukemia
  • Huntsville, Alabama
  • +44 more
Nov 18, 2009

Leukemia, Lymphoma, Low-Grade, Lymphoma, Non-Hodgkin's Trial in Ann Arbor (Reduced intensity conditioning, Prophylactic donor

Terminated
  • Leukemia
  • +4 more
  • Reduced intensity conditioning
  • Prophylactic donor leukocyte infusions
  • Ann Arbor, Michigan
    The University of Michigan
Apr 20, 2007